Fatigue News and Research

RSS

SWOG Cancer Research Network clinical trial reveals potential new therapy for Stage 3 or 4 classic Hodgkin lymphoma

A Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment with nivolumab, a PD-1 checkpoint inhibitor, and AVD chemotherapy (N-AVD) had a significantly lower risk of their cancer getting worse than patients treated with brentuximab vedotin, a monoclonal antibody, and AVD (BV-AVD) a year after starting treatment.

4 Jun 2023

Study of immunotherapy for brain cancer metastases shows promising results

In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that 42 percent of patients with metastatic brain cancer benefited from the therapy, with seven patients in the trial surviving longer than two years.

2 Jun 2023

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis.

2 Jun 2023

Men with higher levels of marital satisfaction have lower burnout risk

Workplace burnout is widespread and has a detrimental effect on employee performance, wellbeing, and the overall productivity of the organization.

2 Jun 2023

Is healthy sleep, both before and during the COVID-19 pandemic, prior to SARS-CoV-2 infection, protective against post–COVID-19 condition?

Researchers examined the relationship between multidimensional sleep health and post-coronavirus disease 2019 condition.

1 Jun 2023

Long-term consequences of COVID-19 in patients with inflammatory rheumatic diseases

Studies on the long-term consequences of COVID-19 (long-COVID) in patients with inflammatory rheumatic diseases (iRD) are scarce.

31 May 2023

$Study shows ketamine nasal spray as a safe and effective treatment for refractory migraine$

Study shows ketamine nasal spray as a safe and effective treatment for refractory migraine

Ketamine taken in the form of a nasal spray may prove a safe and effective treatment for refractory chronic migraine, suggests a single centre study, published in the open access journal Regional Anesthesia & Pain Medicine.

30 May 2023

NJHF grants awards to two Kessler Foundation scientists to advance stroke, spinal cord injury research

Annually, New Jersey Health Foundation (NJHF) invites researchers to submit applications for grants aimed at supporting pilot research projects that exhibit promising potential.

30 May 2023

New blood biomarkers can help quantify the brain impact of neurosurgery

Damage to the brains of patients operated on for brain tumors may be assessed by measuring biomarkers in the blood pre- and postoperatively.

30 May 2023

Defining long-COVID using self-reported symptoms

Researchers developed a symptom-based criteria to identify post-acute sequelae of SARS-CoV-2 infection.

30 May 2023

Web-based surveys offer a feasible way to monitor the safety of novel vaccines

Web-based surveys are a feasible way of rapidly collecting drug safety data on novel vaccines when they are rolled out quickly over a large area, according to a new European study involving the UK’s leading drug safety unit.

26 May 2023

Large study uncovers new details about long COVID

Initial findings from a study of nearly 10,000 Americans, many of whom had COVID-19, have uncovered new details about long COVID, the post-infection set of conditions that can affect nearly every tissue and organ in the body.

26 May 2023

Treatment with luspatercept improves red blood cell counts in patients with myelodysplastic syndromes

Treatment with luspatercept improved red blood cell counts and erythroid responses compared to treatment with epoetin alfa in patients with myelodysplastic syndromes (MDS), allowing the majority to no longer require regular blood transfusions.

26 May 2023

RECOVER study: An important step toward defining long COVID

A study led by the National Institutes of Health's RECOVER Initiative and supported by NYU Langone Health, home to the effort's Clinical Science Core (CSC), provides an expanded working definition of long COVID.

25 May 2023

Study elucidates 12 defining symptoms of long COVID

Long COVID, or Post-Acute Sequelae of SARS-CoV-2 infection (PASC), includes a wide range of symptoms that present or persist more than 30 days after COVID-19 infection.

25 May 2023

Exercise capacity found to be lower than expected among people with long COVID

While some patients recover from the effects of SARS-CoV-2 infection, others have experienced the aftereffects of COVID-19 long after the initial infection. One of these long COVID symptoms is reduced exercise capacity.

25 May 2023

Importance of analyzing the impact of life stressors on those with MS

A Michigan Medicine-led study finds that stressors across the lifespan - including poverty, abuse and divorce - are associated with worsening health and functional outcomes for people with multiple sclerosis.

25 May 2023

Mays Cancer Center conducts clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma

The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma (GBM).

24 May 2023

Study analyzes the relationship between tobacco use and cancer-related symptom burden

In a recent study, current smoking and vaping were associated with a higher burden of symptoms among adult cancer survivors, but these symptoms were not related to survivors' desire to quit smoking.

23 May 2023

Study: Mental health programs need to be strengthened to combat increasing stress among first responders

Controlling traumatic situations is synonymous with the daily duties of first responders, yet many mental health programs to combat the increasing stress they encounter are lacking.

22 May 2023

Fatigue News and Research

SWOG Cancer Research Network clinical trial reveals potential new therapy for Stage 3 or 4 classic Hodgkin lymphoma

Study of immunotherapy for brain cancer metastases shows promising results

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Men with higher levels of marital satisfaction have lower burnout risk

Is healthy sleep, both before and during the COVID-19 pandemic, prior to SARS-CoV-2 infection, protective against post–COVID-19 condition?

Long-term consequences of COVID-19 in patients with inflammatory rheumatic diseases

Study shows ketamine nasal spray as a safe and effective treatment for refractory migraine

NJHF grants awards to two Kessler Foundation scientists to advance stroke, spinal cord injury research

New blood biomarkers can help quantify the brain impact of neurosurgery

Defining long-COVID using self-reported symptoms

Web-based surveys offer a feasible way to monitor the safety of novel vaccines

Large study uncovers new details about long COVID

Treatment with luspatercept improves red blood cell counts in patients with myelodysplastic syndromes

RECOVER study: An important step toward defining long COVID

Study elucidates 12 defining symptoms of long COVID

Exercise capacity found to be lower than expected among people with long COVID

Importance of analyzing the impact of life stressors on those with MS

Mays Cancer Center conducts clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma

Study analyzes the relationship between tobacco use and cancer-related symptom burden

Study: Mental health programs need to be strengthened to combat increasing stress among first responders

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News